Genetic modification of cell division loci enables inducible control over animal cell proliferation using ablation link systems.
Single transcription factor Olig2 converts astrocytes to oligodendrocyte lineage cells, resolving treatment complexity from combinatorial cocktails.
Microorganisms with maltose-inducible promoters stimulate biologic production upon exposure to specific nutrients.
Auxotrophic E. coli strains utilize inducible promoters and optimized ribosomal binding sites to boost terpene synthase translation rates.
Standardized intron sequences replace unique prefix and suffix requirements, enabling universal applicability across diverse cloning projects.
A TetR-expressing cell line controls transgene levels via tetracycline-responsive promoters to enable adenoviral vector production.
GATA1, FLI1, and TAL1 transcription factors program pluripotent stem cells into megakaryocyte progenitors, eliminating serum and murine co-culture requirements.
A modified AAV capsid inserts polypeptides into the VP1 structure to enhance muscle tissue expression levels.
An expression vector integrates matrix attachment regions, locus control regions, and a chimeric intron to drive high-level gene transcription.
Cationic peptides on dextran backbones condense nucleic acids, resolving the trade-off between transfection efficiency and cytotoxicity.
Chimeric gene regulatory units combine enhancer, promoter, and intron sequences from different species to drive strong heterologous expression.
A lentiviral vector system delivers an sgRNA library for high-throughput T cell genome editing and screening.
Engineered adenovirus secretes ApoA1 to suppress tumor invasion, delay cachexia, and restore immune surveillance.
Replacing viral enhancers with MHC class I promoters reduces insertional mutagenesis risk while maintaining high transgene expression.
Hybrid promoters combine liver enhancers with muscle elements to drive transgene expression while minimizing liver toxicity.
Chimeric nucleases merge TAL effector specificity with FokI cleavage to resolve low gene targeting efficiency in plants and animals.
Serotype 35 fiber knob adenoviruses target tumor sites via hypoxia-response elements, reducing liver toxicity during systemic administration.
Segmented PCR generates a synthetic combinatorial AAV3 capsid library, resolving sequence bias and low functional variant rates.
A synthetic adenovirus genome incorporates a two-step transcriptional amplification circuit to regulate viral gene expression.
Segmented synthetic promoters resolve packaging capacity limits while maintaining high expression levels in eukaryotic cells.
A genomic insulator element blocks enhancer activity in T lymphocytes to prevent oncogene activation.
BFDV-derived self-replicating vectors bypass nuclear delivery bottlenecks by amplifying gene copy numbers in the cytoplasm to stimulate innate immune responses.
Chimeric promoter sequences merge murine and simian cytomegalovirus elements to overcome species specificity limits and boost recombinant protein yields.
Specific untranslated regions protect mRNA from degradation, enabling transient nuclease expression for precise plant genome editing.
A viral vector delivers complement inhibitors to podocytes using a specific promoter.
An AARE-based regulatory polynucleotide controls Cas9 expression via amino acid starvation, reducing off-target effects.
Functionalized interfering nanoparticles enable targeted delivery of RNA silencing agents while reducing cellular toxicity and immune response.
Inactivating major and cryptic splice donor sites in lentiviral vector genomes to enhance unspliced RNA production.
Artificial mRNA incorporates a 3'-terminal miRNA target sequence and translational repression sequence to enable controlled protein expression.
Recombinant adeno-associated virus delivers brain-derived neurotrophic factor to the hypothalamus.
Engineering Mut- yeast with reduced AOX1/2 and increased ADH2 expression lowers oxygen demand and heat production while maintaining protein yield.